{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:26:18Z","timestamp":1791285978384,"version":"4.1.0"},"reference-count":47,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,5]]},"abstract":"<jats:p content-type=\"fine-print\"><jats:italic>Object.<\/jats:italic> In recent reports, 6 to 19% of meningiomas have been classified as atypical or anaplastic\/malignant. Some atypical and anaplastic meningiomas appear to arise from benign tumors by progression. Telomerase activation has recently been associated with malignant progression of human tumors. The authors have investigated a series of benign, atypical, and anaplastic\/malignant meningiomas for telomerase activity and expression of the telomerase catalytic subunit human telomerase reverse transcriptase (hTERT).<\/jats:p><jats:p content-type=\"fine-print\"><jats:italic>Methods.<\/jats:italic> A quantitative telomeric repeat amplification protocol was used to detect telomerase enzyme activity in seven (21%) of 34 benign, but in nine (75%) of 12 atypical and in seven (100%) of seven anaplastic\/malignant meningiomas. Very high levels of telomerase activity were observed only in highly aggressive tumors. Messenger (m)RNA expression of the catalytic subunit hTERT was found in 11 (33%) of 33 benign, 12 (92%) of 13 atypical, and all seven anaplastic\/malignant tumors. All telomerase-positive lesions were also positive for hTERT mRNA, whereas no telomerase activity was detected in six (21%) of 29 hTERT-positive tumors. This indicates that upregulation of hTERT is the rate-limiting step for telomerase activation in the majority of meningiomas. Expression of telomerase and hTERT was seen in all four tumors with gross brain invasion. All recurrent tumors or meningiomas recurring during follow up expressed hTERT.<\/jats:p><jats:p content-type=\"fine-print\"><jats:italic>Conclusions.<\/jats:italic> The results are consistent with a role for telomerase activation during the development of malignancy in meningiomas. Hence, expression of telomerase activity and hTERT might prove to be potentially useful markers for the evaluation of these tumors.<\/jats:p>","DOI":"10.3171\/jns.2000.92.5.0832","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T17:31:38Z","timestamp":1242235898000},"page":"832-840","source":"Crossref","is-referenced-by-count":51,"title":["Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression"],"prefix":"10.3171","volume":"92","author":[{"given":"Matthias","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjoung-Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Leuenroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkmar H. J.","family":"Hans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"L\u00f6ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"13677","DOI":"10.1073\/pnas.94.25.13677","article-title":"Telomerase activity: a biomarker of cell proliferation, not malignant transformation.","volume":"94","author":"Belair","year":"1997"},{"key":"b2","series-title":"Nature","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/350569a0","article-title":"Structure and function of telomeres.","volume":"350","author":"Blackburn","year":"1991"},{"key":"b3","series-title":"Science","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.279.5349.349","article-title":"Extension of lifespan by introduction of telomerase into normal human cells.","volume":"279","author":"Bodnar","year":"1998"},{"key":"b4","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"9082","DOI":"10.1073\/pnas.92.20.9082","article-title":"Telomerase activity in normal and malignant hematopoietic cells.","volume":"92","author":"Broccoli","year":"1995"},{"key":"b5","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm1197-1271","article-title":"Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines.","volume":"3","author":"Bryan","year":"1997"},{"key":"b6","series-title":"Am J Clin Pathol","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/ajcp\/107.5.548","article-title":"Differential telomerase expression in human primary intracranial tumors.","volume":"107","author":"DeMasters","year":"1997"},{"key":"b7","series-title":"J Clin Pathol","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/jcp.52.3.234","article-title":"Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.","volume":"52","author":"Falchetti","year":"1999"},{"key":"b8","series-title":"Science","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1126\/science.7544491","article-title":"The RNA component of human telomerase.","volume":"269","author":"Feng","year":"1995"},{"key":"b9","series-title":"Trends Genet","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0168-9525(98)01681-3","article-title":"Telomerase activation. One step on the road to cancer?","volume":"15","author":"Greider","year":"1999"},{"key":"b10","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.93.13.6476","article-title":"Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes.","volume":"93","author":"Harle-Bachor","year":"1996"},{"key":"b11","series-title":"Nature","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/345458a0","article-title":"Telomeres shorten during ageing of human fibroblasts.","volume":"345","author":"Harley","year":"1990"},{"key":"b12","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1101\/gad.11.23.3109","article-title":"Human telomerase contains evolutionarily conserved catalytic and structural subunits.","volume":"11","author":"Harrington","year":"1997"},{"key":"b13","series-title":"Meningiomas and Their Surgical Management.","first-page":"34","article-title":"Radiation-induced meningiomas","author":"Harrison","year":"1991"},{"key":"b14","series-title":"Cancer Res","first-page":"2117","article-title":"Telomerase activity and alterations in telomere length in human brain tumors.","volume":"58","author":"Hiraga","year":"1998"},{"key":"b15","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nm0395-249","article-title":"Correlating telomerase activity levels with human neuroblastoma outcomes.","volume":"1","author":"Hiyama","year":"1995"},{"key":"b16","series-title":"Neuropathol Appl Neurobiol","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-2990.1998.00150.x","article-title":"MIB-1 (Ki-67) index and transforming growth factor-\u03b1 (TGF\u03b1) immunoreactivity are significant prognostic predictors for meningiomas.","volume":"24","author":"Hsu","year":"1998"},{"key":"b17","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0090-3019(86)90233-8","article-title":"Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome.","volume":"25","author":"J\u00e4\u00e4skel\u00e4inen","year":"1986"},{"key":"b18","series-title":"Hum Mol Genet","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/hmg\/6.12.2011","article-title":"Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types.","volume":"6","author":"Kilian","year":"1997"},{"key":"b19","series-title":"Science","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer.","volume":"266","author":"Kim","year":"1994"},{"key":"b20","series-title":"Nature","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/23962","article-title":"Both Rb\/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.","volume":"396","author":"Kiyono","year":"1998"},{"key":"b21","series-title":"Histological Typing of Tumours of the Central Nervous System.","first-page":"33","author":"Kleihues","year":"1993"},{"key":"b22","series-title":"J Clin Pathol","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/jcp.51.4.284","article-title":"Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.","volume":"51","author":"Kleinschmidt-DeMasters","year":"1998"},{"key":"b23","series-title":"Acta Neurochir","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/BF02187190","article-title":"Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67\/Feulgen stainings, and cytogenetics.","volume":"137","author":"Kolles","year":"1995"},{"key":"b24","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/554","article-title":"Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.","volume":"19","author":"Kolquist","year":"1998"},{"key":"b25","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S0046-8177(97)90029-0","article-title":"Telomerase activity in ordinary meningiomas predicts poor outcome.","volume":"28","author":"Langford","year":"1997"},{"key":"b26","series-title":"Pathology and Genetics of Tumours of the Nervous System.","first-page":"134","article-title":"Meningiomas","author":"Louis","year":"1997"},{"key":"b27","series-title":"Neurosurgery","first-page":"955","article-title":"Atypical and malignant meningiomas: a clinicopathological review.","volume":"33","author":"Mahmood","year":"1993"},{"key":"b28","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3171\/jns.1992.77.4.0616","article-title":"Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance.","volume":"77","author":"Maier","year":"1992"},{"key":"b29","series-title":"Cell","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0092-8674(00)80538-3","article-title":"hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.","volume":"90","author":"Meyerson","year":"1997"},{"key":"b30","series-title":"Science","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1126\/science.277.5328.955","article-title":"Telomerase catalytic subunit homologs from fission yeast and human.","volume":"277","author":"Nakamura","year":"1997"},{"key":"b31","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<471::AID-CNCR15>3.0.CO;2-U","article-title":"The significant role of telomerase activity in human brain tumors.","volume":"80","author":"Nakatani","year":"1997"},{"key":"b32","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ng0198-65","article-title":"Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas.","volume":"18","author":"Nakayama","year":"1998"},{"key":"b33","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1101\/gad.12.8.1073","article-title":"The telomerase reverse transcriptase: components and regulation.","volume":"12","author":"Nugent","year":"1998"},{"key":"b34","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3171\/jns.1997.86.5.0793","article-title":"Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.","volume":"86","author":"Palma","year":"1997"},{"key":"b35","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/(SICI)1097-0215(19990820)84:4<426::AID-IJC17>3.0.CO;2-1","article-title":"Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors.","volume":"84","author":"Park","year":"1999"},{"key":"b36","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M","article-title":"\u201cMalignancy\u201d in meningiomas. A clinicopathologic study of 116 patients, with gradings implications.","volume":"85","author":"Perry","year":"1999"},{"key":"b37","series-title":"Am J Surg Pathol","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","article-title":"Meningioma grading. An analysis of histologic parameters.","volume":"21","author":"Perry","year":"1997"},{"key":"b38","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.0.CO;2-R","article-title":"The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.","volume":"82","author":"Perry","year":"1998"},{"key":"b39","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3171\/jns.1989.71.5.0665","article-title":"Incidence and clinicopathological features of meningioma.","volume":"71","author":"Rohringer","year":"1989"},{"key":"b40","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/bjc.1998.267","article-title":"Telomerase activity in 144 brain tumours.","volume":"77","author":"Sano","year":"1998"},{"key":"b41","series-title":"Eur J Cancer","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer.","volume":"33","author":"Shay","year":"1997"},{"key":"b42","series-title":"Cancer Res","first-page":"4696","article-title":"Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.","volume":"55","author":"Simon","year":"1995"},{"key":"b43","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1002\/1097-0142(19891201)64:11<2243::AID-CNCR2820641110>3.0.CO;2-S","article-title":"Establishment of a human malignant meningioma cell line with amplified c-myc oncogene.","volume":"64","author":"Tanaka","year":"1989"},{"key":"b44","series-title":"Cancer Res","first-page":"4168","article-title":"Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.","volume":"58","author":"Ulaner","year":"1998"},{"key":"b45","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1101\/gad.12.12.1769","article-title":"Myc activates telomerase.","volume":"12","author":"Wang","year":"1998"},{"key":"b46","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/ng1297-498","article-title":"Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.","volume":"17","author":"Weinrich","year":"1997"},{"key":"b47","series-title":"Dev Genet","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/(SICI)1520-6408(1996)18:2<173::AID-DVG10>3.0.CO;2-3","article-title":"Telomerase activity in human germline and embryonic tissues and cells.","volume":"18","author":"Wright","year":"1996"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/92\/5\/article-p832.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/92\/5\/article-p832.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/92\/5\/article-p832.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T04:57:52Z","timestamp":1679893072000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/92\/5\/article-p832.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":47,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/jns.2000.92.5.0832","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}